ReP USP - Resultado da busca

Artigo de periodico
MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways (2021)
Veronez, Luciana Chain ; Chagas, Pablo F. das; Correa, Carolina Alves Pereira ; Baroni, Mirella; Silva, Keteryne Rodrigues da ; Nagano, Luís Fernando Peinado ; Borges, Kleiton S; Queiroz, Rosane Gomes de Paula; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Source: Journal of Cellular Biochemistry. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS, CARCINOMA, CÓRTEX ADRENAL, BIOMARCADORES, REGULAÇÃO NEOPLÁSICA DA EXPRESSÃO GÊNICA, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERONEZ, Luciana Chain et al. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, v. 122, n. 12, p. 1925-1935, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcb.30153. Acesso em: 04 nov. 2024.
APA
Veronez, L. C., Chagas, P. F. das, Correa, C. A. P., Baroni, M., Silva, K. R. da, Nagano, L. F. P., et al. (2021). MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, 122( 12), 1925-1935. doi:10.1002/jcb.30153
NLM
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/jcb.30153
Vancouver
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/jcb.30153
Artigo de periodico-carta/editorial
Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets? (2020)
Valera, Elvis Terci; Brassesco, Maria Sol ; Reis, Maristella Bergamo Francisco dos; Maggioni, Gilberto; Guerino-Cunha, Renato Luiz; Grecco, Carlos Eduardo; Elias Júnior, Jorge ; Kato, Mery; Tone, Luiz Gonzaga
Source: Pediatric Hematology and Oncology. Unidades: FMRP, FFCLRP
Subjects: ANTICORPOS MONOCLONAIS, HISTIOCITOSE, NEOPLASIAS POR TIPO HISTOLÓGICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALERA, Elvis Terci et al. Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets?. Pediatric Hematology and Oncology. Abingdon: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1080/08880018.2020.1811438. Acesso em: 04 nov. 2024. , 2020
APA
Valera, E. T., Brassesco, M. S., Reis, M. B. F. dos, Maggioni, G., Guerino-Cunha, R. L., Grecco, C. E., et al. (2020). Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets? Pediatric Hematology and Oncology. Abingdon: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1080/08880018.2020.1811438
NLM
Valera ET, Brassesco MS, Reis MBF dos, Maggioni G, Guerino-Cunha RL, Grecco CE, Elias Júnior J, Kato M, Tone LG. Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets? [Internet]. Pediatric Hematology and Oncology. 2020 ; 38( 1): 89-96.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1080/08880018.2020.1811438
Vancouver
Valera ET, Brassesco MS, Reis MBF dos, Maggioni G, Guerino-Cunha RL, Grecco CE, Elias Júnior J, Kato M, Tone LG. Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child. [Carta]: Is it time to consider new targets? [Internet]. Pediatric Hematology and Oncology. 2020 ; 38( 1): 89-96.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1080/08880018.2020.1811438
Artigo de periodico
Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) (2014)
Leite, Fabíola A; Lira, Régia C. P; Fedatto, Paola F; Antonini, Sonir Roberto Rauber; Martinelli Junior, Carlos Eduardo; Castro, Margaret de; Neder, Luciano; Ramalho, Leandra Naíra Zambelli; Tucci Júnior, Silvio; Mastelaro, Maria J; Seidinger, Ana L; Cardinalli, Izilda A; Yunes, José A; Brandalise, Silvia R; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Pediatric Blood and Cancer. Unidade: FMRP
Subjects: NEOPLASIAS DO CÓRTEX SUPRARRENAL, CRIANÇAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Fabíola A et al. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT). Pediatric Blood and Cancer, v. 61, n. 11, p. 1940-1948, 2014Tradução . . Disponível em: https://doi.org/10.1002/pbc.25118. Acesso em: 04 nov. 2024.
APA
Leite, F. A., Lira, R. C. P., Fedatto, P. F., Antonini, S. R. R., Martinelli Junior, C. E., Castro, M. de, et al. (2014). Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT). Pediatric Blood and Cancer, 61( 11), 1940-1948. doi:10.1002/pbc.25118
NLM
Leite FA, Lira RCP, Fedatto PF, Antonini SRR, Martinelli Junior CE, Castro M de, Neder L, Ramalho LNZ, Tucci Júnior S, Mastelaro MJ, Seidinger AL, Cardinalli IA, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) [Internet]. Pediatric Blood and Cancer. 2014 ; 61( 11): 1940-1948.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/pbc.25118
Vancouver
Leite FA, Lira RCP, Fedatto PF, Antonini SRR, Martinelli Junior CE, Castro M de, Neder L, Ramalho LNZ, Tucci Júnior S, Mastelaro MJ, Seidinger AL, Cardinalli IA, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT) [Internet]. Pediatric Blood and Cancer. 2014 ; 61( 11): 1940-1948.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/pbc.25118
Artigo de periodico
Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia (2013)
Silveira, Vanessa S; Scrideli, Carlos Alberto; Moreno, Daniel A; Yunes, José Andres; Queiroz, Rosane Gomes de Paula; Toledo, Silvia C; Lee, Maria Lúcia M.; Petrilli, Antonio S; Brandalise, Silvia R; Tone, Luiz Gonzaga
Source: Leukemia and Lymphoma. Unidade: FMRP
Subjects: LEUCEMIA, EXPRESSÃO GÊNICA, QUIMIOTERAPIA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Vanessa S et al. Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia. Leukemia and Lymphoma, v. 54, n. 2, p. 310-314, 2013Tradução . . Disponível em: https://doi.org/10.3109/10428194.2012.710330. Acesso em: 04 nov. 2024.
APA
Silveira, V. S., Scrideli, C. A., Moreno, D. A., Yunes, J. A., Queiroz, R. G. de P., Toledo, S. C., et al. (2013). Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia. Leukemia and Lymphoma, 54( 2), 310-314. doi:10.3109/10428194.2012.710330
NLM
Silveira VS, Scrideli CA, Moreno DA, Yunes JA, Queiroz RG de P, Toledo SC, Lee MLM, Petrilli AS, Brandalise SR, Tone LG. Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia [Internet]. Leukemia and Lymphoma. 2013 ; 54( 2): 310-314.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3109/10428194.2012.710330
Vancouver
Silveira VS, Scrideli CA, Moreno DA, Yunes JA, Queiroz RG de P, Toledo SC, Lee MLM, Petrilli AS, Brandalise SR, Tone LG. Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia [Internet]. Leukemia and Lymphoma. 2013 ; 54( 2): 310-314.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3109/10428194.2012.710330
Artigo de periodico
Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells (2012)
Borges, Kleiton Silva; Gamero, Angel Mauricio Castro; Moreno, Daniel Antunes; Silveira, Vanessa da Silva; Brassesco, Maria Sol; Queiroz, Rosane Gomes de Paula; Oliveira, Harley Francisco de; Carlotti Júnior, Carlos Gilberto; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Journal of Cancer Research and Clinical Oncology. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, PROTEÍNAS QUINASES, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Kleiton Silva et al. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. Journal of Cancer Research and Clinical Oncology, v. 138, n. 3, p. 405-414, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00432-011-1111-0. Acesso em: 04 nov. 2024.
APA
Borges, K. S., Gamero, A. M. C., Moreno, D. A., Silveira, V. da S., Brassesco, M. S., Queiroz, R. G. de P., et al. (2012). Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. Journal of Cancer Research and Clinical Oncology, 138( 3), 405-414. doi:10.1007/s00432-011-1111-0
NLM
Borges KS, Gamero AMC, Moreno DA, Silveira V da S, Brassesco MS, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells [Internet]. Journal of Cancer Research and Clinical Oncology. 2012 ; 138( 3): 405-414.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/s00432-011-1111-0
Vancouver
Borges KS, Gamero AMC, Moreno DA, Silveira V da S, Brassesco MS, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Inhibition of Aurora Kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells [Internet]. Journal of Cancer Research and Clinical Oncology. 2012 ; 138( 3): 405-414.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/s00432-011-1111-0
Artigo de periodico
Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia (2012)
Biojone, Estefânia; Queiroz, Rosane Gomes de Paula; Valera, Elvis Terci; Odashima, Newton Satoro; Takayanagui, Osvaldo Massaiti; Viana, Marcos Borato; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Leukemia & Lymphoma. Unidade: FMRP
Subjects: LEUCEMIA (TRATAMENTO), CRIANÇAS, LÍQUIDO CEFALORRAQUIDIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIOJONE, Estefânia et al. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia. Leukemia & Lymphoma, v. 53, n. 1, p. 89-95, 2012Tradução . . Disponível em: https://doi.org/10.3109/10428194.2011.606939. Acesso em: 04 nov. 2024.
APA
Biojone, E., Queiroz, R. G. de P., Valera, E. T., Odashima, N. S., Takayanagui, O. M., Viana, M. B., et al. (2012). Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia. Leukemia & Lymphoma, 53( 1), 89-95. doi:10.3109/10428194.2011.606939
NLM
Biojone E, Queiroz RG de P, Valera ET, Odashima NS, Takayanagui OM, Viana MB, Tone LG, Scrideli CA. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia [Internet]. Leukemia & Lymphoma. 2012 ; 53( 1): 89-95.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3109/10428194.2011.606939
Vancouver
Biojone E, Queiroz RG de P, Valera ET, Odashima NS, Takayanagui OM, Viana MB, Tone LG, Scrideli CA. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia [Internet]. Leukemia & Lymphoma. 2012 ; 53( 1): 89-95.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3109/10428194.2011.606939
Artigo de periodico
Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas? (2012)
Valera, Elvis Terci; Brassesco, Maria Sol; Scrideli, Carlos Alberto; Barros, Marcus Vinicius de Castro; Santos, Antônio Carlos dos; Oliveira, Ricardo Santos de; Machado, Hélio Rubens; Tone, Luiz Gonzaga
Source: Child's Nervous System. Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, PEDIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALERA, Elvis Terci et al. Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas?. Child's Nervous System, v. 28, n. 1, p. 19-22, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00381-011-1601-z. Acesso em: 04 nov. 2024.
APA
Valera, E. T., Brassesco, M. S., Scrideli, C. A., Barros, M. V. de C., Santos, A. C. dos, Oliveira, R. S. de, et al. (2012). Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas? Child's Nervous System, 28( 1), 19-22. doi:10.1007/s00381-011-1601-z
NLM
Valera ET, Brassesco MS, Scrideli CA, Barros MV de C, Santos AC dos, Oliveira RS de, Machado HR, Tone LG. Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas? [Internet]. Child's Nervous System. 2012 ; 28( 1): 19-22.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/s00381-011-1601-z
Vancouver
Valera ET, Brassesco MS, Scrideli CA, Barros MV de C, Santos AC dos, Oliveira RS de, Machado HR, Tone LG. Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas? [Internet]. Child's Nervous System. 2012 ; 28( 1): 19-22.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1007/s00381-011-1601-z
Artigo de periodico
Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis (2012)
Lorea, Cecília Fernandes; Moreno, Daniel Antunes; Borges, Kleiton Silva; Martinelli Junior, Carlos Eduardo; Antonini, Sonir Roberto Rauber; Castro, Margaret de; Tucci Júnior, Silvio; Neder, Luciano; Ramalho, Leandra Naíra Zambelli; Cardinalli, Izilda; Seidinger, Ana Luiza; Mastellaro, Maria José; Yunes, Jose Andres; Brandalise, Silvia Regina; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: European journal of Endocrinology. Unidade: FMRP
Subjects: APOPTOSE, CRIANÇAS, NEOPLASIAS DAS GLÂNDULAS SUPRARRENAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOREA, Cecília Fernandes et al. Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis. European journal of Endocrinology, v. 167, n. 12, p. 199-208, 2012Tradução . . Disponível em: https://doi.org/10.1530/EJE-12-0183. Acesso em: 04 nov. 2024.
APA
Lorea, C. F., Moreno, D. A., Borges, K. S., Martinelli Junior, C. E., Antonini, S. R. R., Castro, M. de, et al. (2012). Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis. European journal of Endocrinology, 167( 12), 199-208. doi:10.1530/EJE-12-0183
NLM
Lorea CF, Moreno DA, Borges KS, Martinelli Junior CE, Antonini SRR, Castro M de, Tucci Júnior S, Neder L, Ramalho LNZ, Cardinalli I, Seidinger AL, Mastellaro MJ, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis [Internet]. European journal of Endocrinology. 2012 ; 167( 12): 199-208.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1530/EJE-12-0183
Vancouver
Lorea CF, Moreno DA, Borges KS, Martinelli Junior CE, Antonini SRR, Castro M de, Tucci Júnior S, Neder L, Ramalho LNZ, Cardinalli I, Seidinger AL, Mastellaro MJ, Yunes JA, Brandalise SR, Tone LG, Scrideli CA. Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis [Internet]. European journal of Endocrinology. 2012 ; 167( 12): 199-208.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1530/EJE-12-0183
Artigo de periodico
Mucoepidermoid carcinoma of the lung arising at the primary site of a bronchogenic cyst: clinical, cytogenetic, and molecular findings (2011)
Brassesco, Maria Sol; Valera, Elvis Terci; Lira, Régia Caroline Peixoto; Torres, Lidia Alice Gomes Monteiro Marin; Scrideli, Carlos Alberto; Elias Júnior, Jorge; Teixeira, Sara Reis; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Unidade: FMRP
Subjects: CISTOS, CARCINOMA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, Maria Sol et al. Mucoepidermoid carcinoma of the lung arising at the primary site of a bronchogenic cyst: clinical, cytogenetic, and molecular findings. Pediatric Blood & Cancer, v. 56, n. 2, 2011Tradução . . Disponível em: https://doi.org/10.1002/pbc.22872. Acesso em: 04 nov. 2024.
APA
Brassesco, M. S., Valera, E. T., Lira, R. C. P., Torres, L. A. G. M. M., Scrideli, C. A., Elias Júnior, J., et al. (2011). Mucoepidermoid carcinoma of the lung arising at the primary site of a bronchogenic cyst: clinical, cytogenetic, and molecular findings. Pediatric Blood & Cancer, 56( 2). doi:10.1002/pbc.22872
NLM
Brassesco MS, Valera ET, Lira RCP, Torres LAGMM, Scrideli CA, Elias Júnior J, Teixeira SR, Tone LG. Mucoepidermoid carcinoma of the lung arising at the primary site of a bronchogenic cyst: clinical, cytogenetic, and molecular findings [Internet]. Pediatric Blood & Cancer. 2011 ; 56( 2):[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/pbc.22872
Vancouver
Brassesco MS, Valera ET, Lira RCP, Torres LAGMM, Scrideli CA, Elias Júnior J, Teixeira SR, Tone LG. Mucoepidermoid carcinoma of the lung arising at the primary site of a bronchogenic cyst: clinical, cytogenetic, and molecular findings [Internet]. Pediatric Blood & Cancer. 2011 ; 56( 2):[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/pbc.22872
Artigo de periodico
Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL) (2011)
Mata, Juliana França da; Silveira, Vanessa da Silva; Mateo, Elvis Cristian Cueva; Cortez, Maria Angélica Abdalla de Freitas; Queiroz, Rosane Gomes de Paula; Yunes, Jose Andres; Lee, Maria Lúcia de Martino; Toledo, Silvia Regina Caminada de; Petrilli, Antônio Sérgio; Brandalise, Silvia Regina; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Pediatric Blood & Cancer. Unidade: FMRP
Subjects: APOPTOSE, CRIANÇAS, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATA, Juliana França da et al. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer, v. 55, n. 1, p. 100-107, 2011Tradução . . Disponível em: https://doi.org/10.1002/pbc.22463. Acesso em: 04 nov. 2024.
APA
Mata, J. F. da, Silveira, V. da S., Mateo, E. C. C., Cortez, M. A. A. de F., Queiroz, R. G. de P., Yunes, J. A., et al. (2011). Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer, 55( 1), 100-107. doi:10.1002/pbc.22463
NLM
Mata JF da, Silveira V da S, Mateo ECC, Cortez MAA de F, Queiroz RG de P, Yunes JA, Lee ML de M, Toledo SRC de, Petrilli AS, Brandalise SR, Tone LG, Scrideli CA. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL) [Internet]. Pediatric Blood & Cancer. 2011 ; 55( 1): 100-107.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/pbc.22463
Vancouver
Mata JF da, Silveira V da S, Mateo ECC, Cortez MAA de F, Queiroz RG de P, Yunes JA, Lee ML de M, Toledo SRC de, Petrilli AS, Brandalise SR, Tone LG, Scrideli CA. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL) [Internet]. Pediatric Blood & Cancer. 2011 ; 55( 1): 100-107.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/pbc.22463
Artigo de periodico
Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil (2011)
Wunsch Filho, Victor; Pelissari, Daniele Maria; Barbieri, Flavio Eitor; Sant'anna, Leonel; Oliveira, Claudia Teresa de; Mata, Juliana França da; Tone, Luiz Gonzaga; Lee, Maria Lúcia de Martino; Andrea, Maria Lydia Mello de; Bruniera, Paula; Epelman, Sidnei; Odone Filho, Vicente; Kheifets, Leeka
Source: Cancer Epidemiology. Unidades: FSP, FMRP, FM
Subjects: CAMPO ELETROMAGNÉTICO, LEUCEMIA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WUNSCH FILHO, Victor et al. Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil. Cancer Epidemiology, v. 35, n. 6, p. 534-539, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.canep.2011.05.008. Acesso em: 04 nov. 2024.
APA
Wunsch Filho, V., Pelissari, D. M., Barbieri, F. E., Sant'anna, L., Oliveira, C. T. de, Mata, J. F. da, et al. (2011). Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil. Cancer Epidemiology, 35( 6), 534-539. doi:10.1016/j.canep.2011.05.008
NLM
Wunsch Filho V, Pelissari DM, Barbieri FE, Sant'anna L, Oliveira CT de, Mata JF da, Tone LG, Lee ML de M, Andrea MLM de, Bruniera P, Epelman S, Odone Filho V, Kheifets L. Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil [Internet]. Cancer Epidemiology. 2011 ; 35( 6): 534-539.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.canep.2011.05.008
Vancouver
Wunsch Filho V, Pelissari DM, Barbieri FE, Sant'anna L, Oliveira CT de, Mata JF da, Tone LG, Lee ML de M, Andrea MLM de, Bruniera P, Epelman S, Odone Filho V, Kheifets L. Exposure to magnetic fileds and childhood acute lymphocytic leukemia in São Paulo, Brazil [Internet]. Cancer Epidemiology. 2011 ; 35( 6): 534-539.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.canep.2011.05.008
Artigo de periodico-carta/editorial
Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor] (2011)
Valera, Elvis Terci; Queiroz, Rosane Gomes de Paula; Brassesco, María Sol; Scrideli, Carlos Alberto; Neves, Fábia; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Unidade: FMRP
Subjects: ANTICORPOS MONOCLONAIS (TERAPIA), CRIANÇAS, LINFOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALERA, Elvis Terci et al. Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor]. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2011
APA
Valera, E. T., Queiroz, R. G. de P., Brassesco, M. S., Scrideli, C. A., Neves, F., & Tone, L. G. (2011). Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor]. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Valera ET, Queiroz RG de P, Brassesco MS, Scrideli CA, Neves F, Tone LG. Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor]. Pediatric Blood & Cancer. 2011 ;[citado 2024 nov. 04 ]
Vancouver
Valera ET, Queiroz RG de P, Brassesco MS, Scrideli CA, Neves F, Tone LG. Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-hodgkin lymphoma. [Carta ao Editor]. Pediatric Blood & Cancer. 2011 ;[citado 2024 nov. 04 ]
Artigo de periodico
Wnt/β-catenin pathway deregulation in childhood adrenocortical tumors (2011)
Leal, Letícia Ferro; Mermejo, Lívia Mara; Ramalho, Leandra Naíra Zambelli; Martinelli Junior, Carlos Eduardo; Yunes, Jose Andres; Seidinger, Ana Luiza; Mastellaro, Maria José; Cardinalli, Izilda Aparecida; Brandalise, Silvia Regina; Moreira, Ayrton Custódio; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto; Castro, Margaret de; Antonini, Sonir Roberto Rauber
Source: Journal of Clinical Endocrinology and Metabolism. Unidade: FMRP
Subjects: CRIANÇAS, NEOPLASIAS DO CÓRTEX SUPRARRENAL, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia Ferro et al. Wnt/β-catenin pathway deregulation in childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, v. 96, n. 10, p. 3106-3114, 2011Tradução . . Acesso em: 04 nov. 2024.
APA
Leal, L. F., Mermejo, L. M., Ramalho, L. N. Z., Martinelli Junior, C. E., Yunes, J. A., Seidinger, A. L., et al. (2011). Wnt/β-catenin pathway deregulation in childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, 96( 10), 3106-3114.
NLM
Leal LF, Mermejo LM, Ramalho LNZ, Martinelli Junior CE, Yunes JA, Seidinger AL, Mastellaro MJ, Cardinalli IA, Brandalise SR, Moreira AC, Tone LG, Scrideli CA, Castro M de, Antonini SRR. Wnt/β-catenin pathway deregulation in childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism. 2011 ; 96( 10): 3106-3114.[citado 2024 nov. 04 ]
Vancouver
Leal LF, Mermejo LM, Ramalho LNZ, Martinelli Junior CE, Yunes JA, Seidinger AL, Mastellaro MJ, Cardinalli IA, Brandalise SR, Moreira AC, Tone LG, Scrideli CA, Castro M de, Antonini SRR. Wnt/β-catenin pathway deregulation in childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism. 2011 ; 96( 10): 3106-3114.[citado 2024 nov. 04 ]
Artigo de periodico
Secondary PSF/TFE3-associated renal cell carcinoma in a child treated for genitourinary rhabdomyosarcoma (2011)
Brassesco, María Sol; Valera, Elvis Terci; Bonilha, Thais Alcantara; Scrideli, Carlos Alberto; Oliveira, Jaqueline Carvalho de; Pezuk, Julia Alejandra; Silva, Gyl Eanes Barros; Costa, Roberto Silva; Tone, Luiz Gonzaga
Source: Cancer Genetics. Unidade: FMRP
Subjects: CARCINOMA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, María Sol et al. Secondary PSF/TFE3-associated renal cell carcinoma in a child treated for genitourinary rhabdomyosarcoma. Cancer Genetics, v. 204, n. 2, p. 108-110, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.cancergencyto.2010.10.006. Acesso em: 04 nov. 2024.
APA
Brassesco, M. S., Valera, E. T., Bonilha, T. A., Scrideli, C. A., Oliveira, J. C. de, Pezuk, J. A., et al. (2011). Secondary PSF/TFE3-associated renal cell carcinoma in a child treated for genitourinary rhabdomyosarcoma. Cancer Genetics, 204( 2), 108-110. doi:10.1016/j.cancergencyto.2010.10.006
NLM
Brassesco MS, Valera ET, Bonilha TA, Scrideli CA, Oliveira JC de, Pezuk JA, Silva GEB, Costa RS, Tone LG. Secondary PSF/TFE3-associated renal cell carcinoma in a child treated for genitourinary rhabdomyosarcoma [Internet]. Cancer Genetics. 2011 ; 204( 2): 108-110.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.cancergencyto.2010.10.006
Vancouver
Brassesco MS, Valera ET, Bonilha TA, Scrideli CA, Oliveira JC de, Pezuk JA, Silva GEB, Costa RS, Tone LG. Secondary PSF/TFE3-associated renal cell carcinoma in a child treated for genitourinary rhabdomyosarcoma [Internet]. Cancer Genetics. 2011 ; 204( 2): 108-110.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.cancergencyto.2010.10.006
Artigo de periodico
Accurate determination of energy needs in children and adolescents with cancer (2011)
Galati, Paula Cristina; Resende, Cristina Maria Mendes; Salomão, Roberta Garcia; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Monteiro, Jacqueline Pontes
Source: Nutrition and Cancer. Unidade: FMRP
Subjects: CRIANÇAS, ADOLESCENTES, NEOPLASIAS, ESTADO NUTRICIONAL, PESOS E MEDIDAS CORPORAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALATI, Paula Cristina et al. Accurate determination of energy needs in children and adolescents with cancer. Nutrition and Cancer, v. 63, n. 2, p. 306-313, 2011Tradução . . Acesso em: 04 nov. 2024.
APA
Galati, P. C., Resende, C. M. M., Salomão, R. G., Scrideli, C. A., Tone, L. G., & Monteiro, J. P. (2011). Accurate determination of energy needs in children and adolescents with cancer. Nutrition and Cancer, 63( 2), 306-313.
NLM
Galati PC, Resende CMM, Salomão RG, Scrideli CA, Tone LG, Monteiro JP. Accurate determination of energy needs in children and adolescents with cancer. Nutrition and Cancer. 2011 ; 63( 2): 306-313.[citado 2024 nov. 04 ]
Vancouver
Galati PC, Resende CMM, Salomão RG, Scrideli CA, Tone LG, Monteiro JP. Accurate determination of energy needs in children and adolescents with cancer. Nutrition and Cancer. 2011 ; 63( 2): 306-313.[citado 2024 nov. 04 ]
Artigo de periodico
BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity (2011)
Morales, Andressa Gois; Brassesco, Maria Sol; Pezuk, Julia Alejandra; Oliveira, Jaqueline Carvalho de; Montaldi, Ana Paula; Hojo, Elza Tiemi Sakamoto; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Anti-Cancer Drugs. Unidades: IB, FFCLRP, FMRP
Subjects: OSTEOSSARCOMA (TRATAMENTO), FÁRMACOS, MITOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORALES, Andressa Gois et al. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, v. 22, n. 10, p. 995-1001, 2011Tradução . . Disponível em: https://doi.org/10.1097/cad.0b013e32834a16d4. Acesso em: 04 nov. 2024.
APA
Morales, A. G., Brassesco, M. S., Pezuk, J. A., Oliveira, J. C. de, Montaldi, A. P., Hojo, E. T. S., et al. (2011). BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, 22( 10), 995-1001. doi:10.1097/cad.0b013e32834a16d4
NLM
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4
Vancouver
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4
Artigo de periodico
Clonal complex chromosome aberration in non-ossifying fibroma (2010)
Brassesco, María Sol; Valera, Elvis Terci; Engel, Edgard Eduard; Barbosa, Marcello Henrique Nogueira; Becker, Aline Paixão; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood &Cancer. Unidade: FMRP
Subjects: FIBROMA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, María Sol et al. Clonal complex chromosome aberration in non-ossifying fibroma. Pediatric Blood &Cancer, v. 54, n. 5, p. 764-767, 2010Tradução . . Disponível em: https://doi.org/10.1002/pbc.22393. Acesso em: 04 nov. 2024.
APA
Brassesco, M. S., Valera, E. T., Engel, E. E., Barbosa, M. H. N., Becker, A. P., Scrideli, C. A., & Tone, L. G. (2010). Clonal complex chromosome aberration in non-ossifying fibroma. Pediatric Blood &Cancer, 54( 5), 764-767. doi:10.1002/pbc.22393
NLM
Brassesco MS, Valera ET, Engel EE, Barbosa MHN, Becker AP, Scrideli CA, Tone LG. Clonal complex chromosome aberration in non-ossifying fibroma [Internet]. Pediatric Blood &Cancer. 2010 ; 54( 5): 764-767.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/pbc.22393
Vancouver
Brassesco MS, Valera ET, Engel EE, Barbosa MHN, Becker AP, Scrideli CA, Tone LG. Clonal complex chromosome aberration in non-ossifying fibroma [Internet]. Pediatric Blood &Cancer. 2010 ; 54( 5): 764-767.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/pbc.22393
Artigo de periodico-carta/editorial
Cytogenetic heterogeneity in biphasic synovial sarcoma associated with telomere instability [Carta] (2010)
Brassesco, María Sol; Cortez, Maria Angélica; Valera, Elvis Terci; Engel, Edgard Eduard; Barbosa, Marcello Henrique Nogueira; Becker, Aline Nazareth de Paiva Paixão; Tone, Luiz Gonzaga
Source: Cancer Genetics and Cytogenetics. Unidade: FMRP
Subjects: SARCOMA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, María Sol et al. Cytogenetic heterogeneity in biphasic synovial sarcoma associated with telomere instability [Carta]. Cancer Genetics and Cytogenetics. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2010
APA
Brassesco, M. S., Cortez, M. A., Valera, E. T., Engel, E. E., Barbosa, M. H. N., Becker, A. N. de P. P., & Tone, L. G. (2010). Cytogenetic heterogeneity in biphasic synovial sarcoma associated with telomere instability [Carta]. Cancer Genetics and Cytogenetics. New York: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Brassesco MS, Cortez MA, Valera ET, Engel EE, Barbosa MHN, Becker AN de PP, Tone LG. Cytogenetic heterogeneity in biphasic synovial sarcoma associated with telomere instability [Carta]. Cancer Genetics and Cytogenetics. 2010 ; 197( 1): 86-90.[citado 2024 nov. 04 ]
Vancouver
Brassesco MS, Cortez MA, Valera ET, Engel EE, Barbosa MHN, Becker AN de PP, Tone LG. Cytogenetic heterogeneity in biphasic synovial sarcoma associated with telomere instability [Carta]. Cancer Genetics and Cytogenetics. 2010 ; 197( 1): 86-90.[citado 2024 nov. 04 ]
Artigo de periodico
miR-29b and miR-125a regulate podoplanin and supress invasion in glioblastoma (2010)
Cortez, Maria Angélica Abdala; Nicoloso, Milena Sabrina; Shimizu, Massayoshi; Rossi, Simona; Gopisetty, Gopal; Molina, Jennifer R.; Carlotti Júnior, Carlos Gilberto; Tirapelli, Daniela Pretti da Cunha; Neder, Luciano; Brassesco, Maria Sol; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Georgescu, Maria-Magdalena; Zhang, Wei; Puduvalli, Vinay; Calin, George Adrian
Source: Genes, Chromosomes & cancer. Unidade: FMRP
Subjects: NEOPLASIAS, APOPTOSE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORTEZ, Maria Angélica Abdala et al. miR-29b and miR-125a regulate podoplanin and supress invasion in glioblastoma. Genes, Chromosomes & cancer, v. 49, n. 11, p. 981-990, 2010Tradução . . Disponível em: https://doi.org/10.1002/gcc.20808. Acesso em: 04 nov. 2024.
APA
Cortez, M. A. A., Nicoloso, M. S., Shimizu, M., Rossi, S., Gopisetty, G., Molina, J. R., et al. (2010). miR-29b and miR-125a regulate podoplanin and supress invasion in glioblastoma. Genes, Chromosomes & cancer, 49( 11), 981-990. doi:10.1002/gcc.20808
NLM
Cortez MAA, Nicoloso MS, Shimizu M, Rossi S, Gopisetty G, Molina JR, Carlotti Júnior CG, Tirapelli DP da C, Neder L, Brassesco MS, Scrideli CA, Tone LG, Georgescu M-M, Zhang W, Puduvalli V, Calin GA. miR-29b and miR-125a regulate podoplanin and supress invasion in glioblastoma [Internet]. Genes, Chromosomes & cancer. 2010 ; 49( 11): 981-990.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/gcc.20808
Vancouver
Cortez MAA, Nicoloso MS, Shimizu M, Rossi S, Gopisetty G, Molina JR, Carlotti Júnior CG, Tirapelli DP da C, Neder L, Brassesco MS, Scrideli CA, Tone LG, Georgescu M-M, Zhang W, Puduvalli V, Calin GA. miR-29b and miR-125a regulate podoplanin and supress invasion in glioblastoma [Internet]. Genes, Chromosomes & cancer. 2010 ; 49( 11): 981-990.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1002/gcc.20808
Artigo de periodico
mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor (2010)
Scrideli, Carlos Alberto; Cortez, Maria Angela Abdala; Yunes, Jose Andres; Queiroz, Rosane Gomes de Paula; Valera, Elvis Terci; Mata, Juliana França da; Toledo, Silvia Regina Caminada de; Ferreira, Priscila Pavoni; Lee, Maria Lúcia de Martino; Petrilli, Antônio Sérgio; Brandalise, Silvia Regina; Tone, Luiz Gonzaga
Source: Leukemia Research. Unidade: FMRP
Subjects: CRIANÇAS, EXPRESSÃO GÊNICA, LEUCEMIA, MEDULA ÓSSEA (AMOSTRA;DIAGNÓSTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCRIDELI, Carlos Alberto et al. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor. Leukemia Research, v. 34, n. 1, p. 32-37, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2009.10.007. Acesso em: 04 nov. 2024.
APA
Scrideli, C. A., Cortez, M. A. A., Yunes, J. A., Queiroz, R. G. de P., Valera, E. T., Mata, J. F. da, et al. (2010). mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor. Leukemia Research, 34( 1), 32-37. doi:10.1016/j.leukres.2009.10.007
NLM
Scrideli CA, Cortez MAA, Yunes JA, Queiroz RG de P, Valera ET, Mata JF da, Toledo SRC de, Ferreira PP, Lee ML de M, Petrilli AS, Brandalise SR, Tone LG. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor [Internet]. Leukemia Research. 2010 ; 34( 1): 32-37.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.007
Vancouver
Scrideli CA, Cortez MAA, Yunes JA, Queiroz RG de P, Valera ET, Mata JF da, Toledo SRC de, Ferreira PP, Lee ML de M, Petrilli AS, Brandalise SR, Tone LG. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor [Internet]. Leukemia Research. 2010 ; 34( 1): 32-37.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.007

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation